These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

246 related items for PubMed ID: 19887131

  • 1. Evaluation of particulate acellular vaccines against Brucella ovis infection in rams.
    Da Costa Martins R, Irache JM, Blasco JM, Muñoz MP, Marín CM, Jesús Grilló M, Jesús De Miguel M, Barberán M, Gamazo C.
    Vaccine; 2010 Apr 09; 28(17):3038-46. PubMed ID: 19887131
    [Abstract] [Full Text] [Related]

  • 2. Brucella outer membrane complex-loaded microparticles as a vaccine against Brucella ovis in rams.
    Muñoz PM, Estevan M, Marín CM, Jesús De Miguel M, Jesús Grilló M, Barberán M, Irache JM, Blasco JM, Gamazo C.
    Vaccine; 2006 Mar 10; 24(11):1897-905. PubMed ID: 16337315
    [Abstract] [Full Text] [Related]

  • 3. Comparison of subcutaneous and conjunctival routes of Rev 1 vaccination for the prophylaxis of Brucella ovis infection in rams.
    Marín CM, Barberán M, Jiménez de Bagués MP, Blasco JM.
    Res Vet Sci; 1990 Mar 10; 48(2):209-15. PubMed ID: 2110377
    [Abstract] [Full Text] [Related]

  • 4. Efficacy of bp26 and bp26/omp31 B. melitensis Rev.1 deletion mutants against Brucella ovis in rams.
    Grilló MJ, Marín CM, Barberán M, de Miguel MJ, Laroucau K, Jacques I, Blasco JM.
    Vaccine; 2009 Jan 07; 27(2):187-91. PubMed ID: 19007836
    [Abstract] [Full Text] [Related]

  • 5. Characterization of possible correlates of protective response against Brucella ovis infection in rams immunized with the B. melitensis Rev 1 vaccine.
    Galindo RC, Muñoz PM, de Miguel MJ, Marin CM, Blasco JM, Gortazar C, Kocan KM, de la Fuente J.
    Vaccine; 2009 May 18; 27(23):3039-44. PubMed ID: 19428917
    [Abstract] [Full Text] [Related]

  • 6. Design and influence of gamma-irradiation on the biopharmaceutical properties of nanoparticles containing an antigenic complex from Brucella ovis.
    Da Costa Martins R, Gamazo C, Irache JM.
    Eur J Pharm Sci; 2009 Jul 12; 37(5):563-72. PubMed ID: 19442721
    [Abstract] [Full Text] [Related]

  • 7. Acellular vaccines for ovine brucellosis: a safer alternative against a worldwide disease.
    Martins Rda C, Irache JM, Gamazo C.
    Expert Rev Vaccines; 2012 Jan 12; 11(1):87-95. PubMed ID: 22149711
    [Abstract] [Full Text] [Related]

  • 8. Antibody response and antigen-specific gamma-interferon profiles of vaccinated and unvaccinated pregnant sheep experimentally infected with Brucella melitensis.
    Durán-Ferrer M, Léon L, Nielsen K, Caporale V, Mendoza J, Osuna A, Perales A, Smith P, De-Frutos C, Gómez-Martín B, Lucas A, Chico R, Delgado OD, Escabias JC, Arrogante L, Díaz-Parra R, Garrido F.
    Vet Microbiol; 2004 Jun 03; 100(3-4):219-31. PubMed ID: 15145500
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Immunological responses and protective efficacy against Brucella melitensis induced by bp26 and omp31 B. melitensis Rev.1 deletion mutants in sheep.
    Jacques I, Verger JM, Laroucau K, Grayon M, Vizcaino N, Peix A, Cortade F, Carreras F, Guilloteau LA.
    Vaccine; 2007 Jan 15; 25(5):794-805. PubMed ID: 17070627
    [Abstract] [Full Text] [Related]

  • 11. Immunopathological responses and kinetics of Brucella melitensis Rev 1 infection after subcutaneous or conjunctival vaccination in rams.
    Muñoz PM, de Miguel MJ, Grilló MJ, Marín CM, Barberán M, Blasco JM.
    Vaccine; 2008 May 19; 26(21):2562-9. PubMed ID: 18423950
    [Abstract] [Full Text] [Related]

  • 12. Evaluation of whole cell and subcellular vaccines against Brucella ovis in rams.
    Blasco JM, Gamazo C, Winter AJ, Jiménez de Bagüés MP, Marín C, Barberán M, Moriyón I, Alonso-Urmeneta B, Díaz R.
    Vet Immunol Immunopathol; 1993 Aug 19; 37(3-4):257-70. PubMed ID: 8236802
    [Abstract] [Full Text] [Related]

  • 13. Residual virulence and immunogenicity of CGV26 and CGV2631 B. melitensis Rev. 1 deletion mutant strains in sheep after subcutaneous or conjunctival vaccination.
    Guilloteau LA, Laroucau K, Olivier M, Grillo MJ, Marin CM, Verger JM, Blasco JM.
    Vaccine; 2006 Apr 24; 24(17):3461-8. PubMed ID: 16519974
    [Abstract] [Full Text] [Related]

  • 14. Effectivity of Rev 1 vaccine in rams against brucella ovis infection.
    Gradwell DV, Van Zyl FE.
    J S Afr Vet Assoc; 1975 Dec 24; 46(4):349-51. PubMed ID: 1223287
    [Abstract] [Full Text] [Related]

  • 15. The Brucella abortus RB51 vaccine does not confer protection against Brucella ovis in rams.
    Jiménez de Bagüés MP, Barberán M, Marín CM, Blasco JM.
    Vaccine; 1995 Feb 24; 13(3):301-4. PubMed ID: 7631517
    [Abstract] [Full Text] [Related]

  • 16. Ovine brucellosis: repeated vaccination with Rev 1 vaccine and the prevalence of the disease in the Winburg district.
    Erasmus JA, Bergh EC.
    J S Afr Vet Assoc; 1985 Dec 24; 56(4):205-8. PubMed ID: 3836306
    [Abstract] [Full Text] [Related]

  • 17. The polymeric antigen BLSOmp31 confers protection against Brucella ovis infection in rams.
    Estein SM, Fiorentino MA, Paolicchi FA, Clausse M, Manazza J, Cassataro J, Giambartolomei GH, Coria LM, Zylberman V, Fossati CA, Kjeken R, Goldbaum FA.
    Vaccine; 2009 Nov 12; 27(48):6704-11. PubMed ID: 19748579
    [Abstract] [Full Text] [Related]

  • 18. Development and evaluation as vaccines in mice of Brucella melitensis Rev.1 single and double deletion mutants of the bp26 and omp31 genes coding for antigens of diagnostic significance in ovine brucellosis.
    Cloeckaert A, Jacques I, Grilló MJ, Marín CM, Grayon M, Blasco JM, Verger JM.
    Vaccine; 2004 Jul 29; 22(21-22):2827-35. PubMed ID: 15246618
    [Abstract] [Full Text] [Related]

  • 19. Mucosal immunization with polymeric antigen BLSOmp31 using alternative delivery systems against Brucella ovis in rams.
    Díaz AG, Quinteros DA, Paolicchi FA, Rivero MA, Palma SD, Pardo RP, Clausse M, Zylberman V, Goldbaum FA, Estein SM.
    Vet Immunol Immunopathol; 2019 Mar 29; 209():70-77. PubMed ID: 30885309
    [Abstract] [Full Text] [Related]

  • 20. A recombinant subunit vaccine based on the insertion of 27 amino acids from Omp31 to the N-terminus of BLS induced a similar degree of protection against B. ovis than Rev.1 vaccination.
    Cassataro J, Pasquevich KA, Estein SM, Laplagne DA, Velikovsky CA, de la Barrera S, Bowden R, Fossati CA, Giambartolomei GH, Goldbaum FA.
    Vaccine; 2007 May 30; 25(22):4437-46. PubMed ID: 17442465
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.